Intravenous (IV) Therapy and Vein Access: Global Markets

Published - Nov 2014| Analyst - Mary C. Patton| Code - HLC046C
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The global market for intravenous therapy and vein access was $19.3 billion in 2013. The market reached $20.3 billion in 2014 and is expected to reach about $27.2 billion in 2019, registering a compound annual growth (CAGR) of 6.0% over the next five years.

Report Includes

  • An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
  • Analyses of market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Detailed information on the main categories for IV therapy including ambulatory infusion pumps, central venous access devices, Diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
  • Identification of current products on the market.
  • Assessments of the competitive landscape and competitor market shares.

 

SCOPE OF THE STUDY

The scope of this study encompasses all intravenous (IV) therapy drugs and devices, including intravenous solutions, administration sets and other accessories, infusion pumps and venous access devices used for therapeutic purposes. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. The report addresses the latest trends and developments in technology. The report also discusses the growing demand for IV therapy drugs and devices in emerging markets, which include countries such as India, China, Japan and Korea.

ANALYST’S CREDENTIALS

Mary C. Patton, M.B.A, D.B.A., is the BCC Research Analyst who authored this report. Dr. Patton’s experience includes over 25 years of designing and managing custom research projects involving both qualitative and quantitative techniques with a broad range of medical, surgical and healthcare industry providers and patients. She has conducted extensive research on surgical devices, diagnostic equipment, specific disease states, EMR systems and PACS systems. She has also worked in product management and strategic management roles for several major medical device manufacturers. Dr. Patton is the author of more than a dozen previous research reports related to the medical device industry.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Aug-2010| Analyst - Mary Anne Crandall| Code - HLC046B

Report Highlights

  • In 2009, the total global intravenous therapy and vein access market reached nearly; $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
  • Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
  • The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.
Published - Aug-2006| Analyst - Mary Anne Crandall| Code - HLC046A

Report Highlights

  • U.S. market revenues for IV therapy and vein access were worth more than $4.6 billion in 2005. At an average annual growth rate (AAGR) of 4.2%, the market will reach almost $5.7 billion by 2010.
  • The market is broken down by ambulatory infusion pumps, enteral feeding pumps, peripheral venous access devices, and syringe infusion pumps. Ambulatory fusion pumps and peripheral venous access devices both held approximately 30% of the market share in 2005. Fusion pumps will maintain the majority of the market through the forecast period, holding a 29% share in 2010.
  • The fastest growing market sector will be syringe infusion pumps, which will have an AAGR of approximately 6.8% through the forecast period.
Need Specific Data Sets?

We can tailor to your project.

Contact Us
RELATED REPORTS
Share This Report